Frost & Sullivan: Australian Pharmaceuticals and Life Sciences IT Market Is Still Growing
According to Frost & Sullivan Consulting Analyst, Sourabh Janardan Kankhar, “The pharmaceuticals industry is one of the leading exporters in the Australian manufacturing sector. At present,
Kankhar further explains, “The majority of multinational industry participants in
The cost-effective drug discovery solutions through in-silico research are driving SME life sciences companies to increase IT spending on enterprise compliances and quality management systems.
Pharmaceuticals companies are continuing to invest in CRM solutions to address the needs of their end clients such as physicians and patients in a better way to maximise sales. Most large pharmaceuticals companies have ERP systems to support SCM, CRM, manufacturing and R&D processes, yet are in silos and often disconnected from each another. However, due to the extensive reach (both geographic and speciality) of MNC operations, efficient data management system is necessary to maximize knowledge sharing among department and locations.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company’s Growth Partnership Service provides the CEO and the CEO’s Growth Team with disciplined research and best practice models to drive the generation, evaluation and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 31 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.
Contact: Emmie Kaur Corporate Communications - Healthcare, Asia Pacific DID: +603 6204 5913 Email: firstname.lastname@example.org Jasminder Kaur Corporate Communications - Healthcare, Asia Pacific DID: +65 6890 0937 Email: email@example.com
SOURCE Frost & Sullivan